Literature DB >> 8536867

The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine.

D S Pratt1, D P Flavin, M M Kaplan.   

Abstract

Although the treatment of choice for autoimmune hepatitis is glucocorticoids, their side effects make long-term use undesirable. Therefore, other immunosuppressive agents have been used to replace glucocorticoids in the long-term treatment of autoimmune hepatitis, including azathioprine, a purine analogue. It is derived from 6-mercaptopurine, and these two drugs are often used interchangeably. However, these drugs have different toxicity profiles and may have clinically relevant differences in immunosuppressive activity in individual patients. We report 3 patients with autoimmune hepatitis who either could not tolerate or failed to improve on azathioprine but responded well to 6-mercaptopurine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8536867     DOI: 10.1053/gast.1996.v110.pm8536867

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

Review 1.  Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination.

Authors:  Albert J Czaja
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

2.  Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine.

Authors:  D G Bowen; W S Selby
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

3.  Autoimmune hepatitis.

Authors:  Joseph Ahn; Steven L Flamm
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

Review 4.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

5.  Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy.

Authors:  Kelly W Burak; Mark G Swain; Tania Santodomingo-Garzon; Tania Santodomino-Garzon; Samuel S Lee; Stefan J Urbanski; Alexander I Aspinall; Carla S Coffin; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2013       Impact factor: 3.522

Review 6.  Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

Authors:  Albert J Czaja; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

7.  Treatment of Autoimmune Hepatitis: Current and Future Therapies.

Authors:  Fernando Alvarez
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10

Review 8.  Drug therapy in the management of type 1 autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

9.  The use of budesonide in the treatment of autoimmune hepatitis in Canada.

Authors:  Iman Zandieh; Darin Krygier; Victor Wong; John Howard; Lawrence Worobetz; Gerald Minuk; Helga Witt-Sullivan; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2008-04       Impact factor: 3.522

10.  Treatment of autoimmune liver disease: current and future therapeutic options.

Authors:  Palak J Trivedi; Gideon M Hirschfield
Journal:  Ther Adv Chronic Dis       Date:  2013-05       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.